Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001127602-23-018783)

Filing Details

Accession Number:: 0001127602-23-018783
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-06-15 16:37:27
Reporting Period:: 2023-06-13

Accepted Time:: 2023-06-15 16:37:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882796	Biocryst Pharmaceuticals Inc	BCRX	Biological Products, (No Disgnostic Substances) (2836)	621413174

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1718020	Machelle Sanders	4505 Emperor Blvd. Suite 200 Durham NC 27703		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-06-13	16,745	$0.00	29,611	No	4	A	Direct
Common Stock	Disposition	2023-06-15	4,000	$7.98	25,611	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Automatic Stock Option Grant	Acquisiton	2023-06-13	39,072	$0.00	39,072	$8.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
39,072	2024-06-13	2033-06-13	No	4	A	Direct

Footnotes

Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.